Virax Biolabs VRAX
NASDAQ VRAX
$2.20 -0.03 (-1.35%)
As of: Sep 30, 2026 · 3:28 PM EDT

Virax Biolabs (VRAX) Short term Debt (2024 - 2026)

Updated

Virax Biolabs' Short term Debt came in at $28,477 for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 12.3% from $32,468 a year earlier.

Analysis

Virax Biolabs (VRAX) Short term Debt (2024 - 2026) Analysis & Trends

Going back to fiscal Q2 2025, Virax Biolabs' Short term Debt data covers 4 quarters.

  • Going back by fiscal year, Short term Debt was $32,468 in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Virax Biolabs 886,625.71 -20.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 28,477.00
Sep 30, 2025 195,577.00
Mar 31, 2025 32,468.00
Sep 30, 2024 222,728.00
API Access

Virax Biolabs Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRAX&period=max&api_key=YOUR_API_KEY